IDEXX Laboratories 8-K Report: Key Updates as of November 3, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

1. Company Information:

• Name: IDEXX Laboratories, Inc.
• CIK (Central Index Key): 0000874716
• SEC Filing Type: 8-K
• Filing Date: November 3, 2025
• Address: One IDEXX Drive, Westbrook, ME 04092

2. Stock Information:

• Common Stock Par Value: $0.10 per share
• Ticker Symbol: IDXX
• Exchange: NASDAQ

3. Reporting Context:

• Report Date: November 3, 2025
• Period Type: The report refers specifically to this single date, indicating it may include information related to specific events or circumstances occurring on this date.

4. Units of Measure:

• Currency: USD (U.S. Dollars)
• Shares: Common stock shares are reported in terms of both currency (USD) and shares.

5. Miscellaneous:

• The report includes information on units of measure for reporting, indicating that the figures may be presented in both currency and shares.

Insights:

• The 8-K filing typically indicates that IDEXX Laboratories is disclosing significant events or changes that are material to the company, which could be crucial for investors and analysts.
• The par value of the common stock is relatively low at $0.10, which is common for many companies, especially in growth sectors like biotechnology.
• The report is dated November 3, 2025, suggesting it reflects the company's current situation or important announcements as of that date, which can be significant for stock performance and investor sentiment.

This information can be useful for assessing the company's position, understanding market activity, and evaluating potential investment opportunities.